Luoxin Pharmaceutical's H1 2026 net profit attributable to parent jumps 182.19% year on year

央广财经··CN·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Luoxin Pharmaceutical disclosed its 2026 semi-annual report, with net profit attributable to shareholders of the listed company up 182.19% year on year. During the period, the company achieved operating revenue of 1.147 billion yuan, up 6.52% year on year; net profit attributable to shareholders of the listed company was 49.9341 million yuan.

Impact on assets 1

Others▲ · 1 stocks
© 2026 MarketIVNews